Physician response to COVID-19-driven telehealth flexibility for opioid use disorder.

ABSTRACT:

Objectives

To learn how preferences and practices regarding telehealth have evolved during the COVID-19 pandemic for physicians who provide opioid use disorder (OUD) treatment.

Study design

Publicly registered physicians who provide OUD treatment were surveyed on their current and retrospective use of telehealth and how their perception of telehealth effectiveness and policy preferences have changed during the COVID-19 pandemic as telehealth regulations were loosened throughout the country.

Methods

The primary survey data were collected in July 2020 leveraging administrative contact information for the population of publicly listed buprenorphine-prescribing physicians in the United States. A total of 1141 physicians received the survey and consented to participate.

SUBMITTER: Beetham T 

PROVIDER: S-EPMC12128386 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature